HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity
- PMID: 17482131
- DOI: 10.1016/j.ccr.2007.04.001
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity
Abstract
Many cancer cells are characterized by increased glycolysis and decreased respiration, even under aerobic conditions. The molecular mechanisms underlying this metabolic reprogramming are unclear. Here we show that hypoxia-inducible factor 1 (HIF-1) negatively regulates mitochondrial biogenesis and O(2) consumption in renal carcinoma cells lacking the von Hippel-Lindau tumor suppressor (VHL). HIF-1 mediates these effects by inhibiting C-MYC activity via two mechanisms. First, HIF-1 binds to and activates transcription of the MXI1 gene, which encodes a repressor of C-MYC transcriptional activity. Second, HIF-1 promotes MXI-1-independent, proteasome-dependent degradation of C-MYC. We demonstrate that transcription of the gene encoding the coactivator PGC-1beta is C-MYC dependent and that loss of PGC-1beta expression is a major factor contributing to reduced respiration in VHL-deficient renal carcinoma cells.
Similar articles
-
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938. Oncogene. 2000. PMID: 11114720
-
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.Cancer Res. 2006 Mar 1;66(5):2725-31. doi: 10.1158/0008-5472.CAN-05-3719. Cancer Res. 2006. PMID: 16510593
-
Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.Cancer Res. 2003 Oct 15;63(20):6877-84. Cancer Res. 2003. PMID: 14583486
-
Energy regulation: HIF MXIes it up with the C-MYC powerhouse.Dev Cell. 2007 Jun;12(6):845-6. doi: 10.1016/j.devcel.2007.05.006. Dev Cell. 2007. PMID: 17543856 Review.
-
HIF-1 mediates the Warburg effect in clear cell renal carcinoma.J Bioenerg Biomembr. 2007 Jun;39(3):231-4. doi: 10.1007/s10863-007-9081-2. J Bioenerg Biomembr. 2007. PMID: 17551816 Review.
Cited by
-
Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury.J Immunol. 2012 May 15;188(10):5106-15. doi: 10.4049/jimmunol.1103377. Epub 2012 Apr 6. J Immunol. 2012. PMID: 22490864 Free PMC article.
-
Hypoxia-inducible factor 1 and breast cancer metastasis.J Zhejiang Univ Sci B. 2015 Jan;16(1):32-43. doi: 10.1631/jzus.B1400221. J Zhejiang Univ Sci B. 2015. PMID: 25559953 Free PMC article. Review.
-
Targeting MYC at the intersection between cancer metabolism and oncoimmunology.Front Immunol. 2024 Feb 8;15:1324045. doi: 10.3389/fimmu.2024.1324045. eCollection 2024. Front Immunol. 2024. PMID: 38390324 Free PMC article. Review.
-
Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy.J Exp Clin Cancer Res. 2020 Sep 14;39(1):185. doi: 10.1186/s13046-020-01698-5. J Exp Clin Cancer Res. 2020. PMID: 32928258 Free PMC article. Review.
-
The association between methylmalonic acid, a biomarker of mitochondrial dysfunction, and risk of prostate cancer.Int Urol Nephrol. 2024 Jun;56(6):1879-1885. doi: 10.1007/s11255-024-03944-7. Epub 2024 Jan 27. Int Urol Nephrol. 2024. PMID: 38280131
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
